Pfiz­er and BioN­Tech re­solve mR­NA patent law­suit filed by Pro­mo­some

Pro­mo­some, Pfiz­er and BioN­Tech told a Cal­i­for­nia fed­er­al judge that they have agreed to re­solve Pro­mo­some’s law­suit ac­cus­ing the two com­pa­nies of vi­o­lat­ing a patent is­sued to its mR­NA tech­nol­o­gy al­most a decade ago.

Mod­er­na, Pfiz­er and BioN­Tech were sued in June by Pro­mo­some, which claimed that the three com­pa­nies vi­o­lat­ed its patent with their vac­cines. “The se­quence un­der­ly­ing de­fen­dants’ Covid-19 vac­cine tells a clear sto­ry: de­fen­dants used the method of the ’179 Patent in their Covid-19 vac­cine,” the small, pri­vate com­pa­ny al­leged in the suit.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.